What move does the options market price into Insmed's report?

Implied ±19.0%, either direction · provisional.

INSMNasdaqPharmaceutical Preparations

Insmed Inc (INSM) earnings date, market-implied expected move, and options open interest by expiry

112.65

Closed17:34 ET

Open112.00Volume5.2MMkt cap$24.7BEPS-2.83

Day108.26 – 114.2174%52-wk90.39 – 212.7518%

INSM

Insmed Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±19.0%implied · straddle

91.20133.96

spot 112.58exp Feb 19ATM strike 115ATM straddle 25.15IV 50%

Oct 30 closeprovisional

Expected move

Inputs

Next report

Feb 18

before open · in 110 days

est.Q4 FY26

Calendar

Next report

Last report

+15.06%

vs ±14.7% implied · ×1.02

shaded = implied · ▲▼ = realized

Oct 29 '26 · confirmed

Implied vs realized

Linked news

1dAZN · supplierAstraZeneca Q3 reported EPS $2.02, total revenue $16,209m; core EPS $2.79

News

Largest filed tie

13F top-10 QoQ

+4.18%

shares held · 10 largest managers

13F · Jun 30 '26124d lag

666 managers

Top fund weight

1.08%

INSM weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Insmed (INSM) is expected to report on Feb 18 before open (estimated date).

Implied vs realized

2 reports

—≥ implied

Q2 FY26Aug 6 '26confirmed±11.7%▲+33.86%×2.90

Q3 FY26Oct 29 '26confirmed±14.7%▲+15.06%×1.02

quarterimplied−35%0+35%realized×

Q3 FY26±14.7%▲+15.06%×1.02

Q2 FY26±11.7%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Oct 29 close

0.29OI · 5 expiries · Oct 29 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

18,265−9%Nov 2020d0.4540,542+12%0.45

91+30%Dec 1848d0.27333+6%0.27

16,3750%Jan 1576d0.3349,4180%0.33

report · Feb 18 · before open · est.

142+1%Feb 19111d4910%

2,3760%Mar 19139d0.832,852+1%0.83

ExpiryPutsCallsP/C

Nov 2020d18,265−9%40,542+12%0.45

Dec 1848d91+30%333+6%0.27

Jan 1576d16,3750%49,4180%0.33

report · Feb 18 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±19.0%

Funds 4

XBI±0.2%

VUG±0.0%

VTI±0.0%

VT±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ3 FY26

−19.13%as filednet margin · revenue +23.25% QoQ · +268.43% YoY

Revenue$524M+23.25%

Gross profit$446M85.09%+24.55%

Operating income−$89M−17.04%−5673.19%

Pre-tax income−$98M−758.64%

Net income−$100M−19.13%−657.58%

Cost of revenue$78M+16.37%

Operating expenses$536M+48.85%

Tax$3M+42.64%

Other expense−$8M+15.68%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Oct 30 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 17:30 ET

Intraday

Event sensitivity

CPI ×2.18· ±4.8% vs ±2.2% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±4.8%4 of 10×2.18

NFPjobs report±2.9%4 of 10×1.34

CPROFcorporate profits±1.7%8 of 12×0.79

PPIproducer prices±1.6%3 of 10×0.75

FOMCrate decision±1.6%11 of 24×0.75

GDPgross domestic product±1.6%13 of 19×0.72

PCEpersonal income & outlays±1.3%14 of 19×0.58

Bar = avg |move| to ±5% · tick = ±2.2% avg day · ×base = |move| ÷ ±2.2% · min 6 releases

Earnings history

EPS -0.46 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Oct 29 '26 · confirmed	-0.46	—
Q2 FY26	Aug 6 '26 · confirmed	-0.06	—
Q1 FY26	—	-0.76	—
Q3 FY25	—	-1.75	—

Methodology

ties · implied moves · holdersMethod